• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在血液透析治疗中实现凝血成分到磷酸盐动力学模型中:一种检测凝血问题的工具?

Implementation of a coagulation component into a phosphate kinetics model in haemodialysis therapy: A tool for detection of clotting problems?

机构信息

The Danish Diabetes Academy, Odense University Hospital, Odense, Denmark.

Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.

出版信息

Exp Physiol. 2023 Oct;108(10):1325-1336. doi: 10.1113/EP091201. Epub 2023 Aug 11.

DOI:10.1113/EP091201
PMID:37566800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10996865/
Abstract

A coagulation component should be considered in phosphate kinetics modelling because intradialytic coagulation of the extracorporeal circuit and dialyser might reduce phosphate removal in haemodialysis. Thus, the objective of this study was to add and evaluate coagulation as an individual linear clearance reduction component to a promising three-compartment model assuming progressive intradialytic clotting. The model was modified and validated on intradialytic plasma and dialysate phosphate samples from 12 haemodialysis patients collected during two treatments (HD1 and HD2) at a Danish hospital ward. The most suitable clearance reduction in each treatment was identified by minimizing the root mean square error (RMSE). The model simulations with and without clearance reduction were compared based on RMSE and coefficient of determination (R ) values. Improvements were found for 17 of the 24 model simulations when clearance reduction was added to the model. The slopes of the clearance reduction were in the range of 0.011-0.632/h. Three improvements were found to be statistically significant (|observed z value| > 1.96). A very significant correlation (R  = 0.708) between the slopes for HD1 and HD2 was found. Adding the clearance reduction component to the model seems promising in phosphate kinetics modelling and might be explained, at least in part, by intradialytic coagulation. In future studies, the model might be developed further to serve as a potentially useful tool for the quantitative detection of clotting problems in haemodialysis. NEW FINDINGS: What is the central question of this study? The aim was to add an intradialytic coagulation component to a modified version of a promising three-compartment phosphate kinetics model. The hypothesis was that circuit and dialyser clotting can be modelled by an individual linear phosphate clearance reduction component during haemodialysis treatment. What is the main finding and its importance? Improvements were found for 17 of 24 model simulations when clearance reduction was added to the model. Thus, the kinetics model seems promising and could be a useful tool for the quantitative detection of clotting problems in haemodialysis patients.

摘要

在磷酸盐动力学建模中应考虑凝血成分,因为体外循环和透析器在透析过程中的凝血可能会降低血液透析中的磷酸盐清除率。因此,本研究的目的是在一个有前途的三腔模型中添加凝血,并将其作为一个单独的线性清除率降低成分进行评估,假设在透析过程中存在逐渐的凝血。该模型在丹麦医院病房的 12 名血液透析患者的两次治疗(HD1 和 HD2)期间收集的透析液和透析液磷酸盐样本中进行了修改和验证。通过最小化均方根误差(RMSE)来确定每个治疗中最适合的清除率降低。基于 RMSE 和决定系数(R)值,比较了添加和不添加清除率降低的模型模拟。当将清除率降低添加到模型中时,24 个模型模拟中有 17 个得到了改善。清除率降低的斜率范围为 0.011-0.632/h。发现有 3 个改进在统计学上是显著的(|观察 z 值|>1.96)。在 HD1 和 HD2 之间发现了非常显著的相关性(R=0.708)。在磷酸盐动力学建模中,向模型添加清除率降低成分似乎很有前途,这至少可以部分解释为透析过程中的凝血。在未来的研究中,该模型可能会进一步发展,成为血液透析中凝血问题定量检测的潜在有用工具。新发现:这项研究的核心问题是什么?目的是在改良的三腔磷酸盐动力学模型中添加一个透析过程中的凝血组件。假设可以通过在血液透析治疗期间使用单独的线性磷酸盐清除率降低成分来模拟体外循环和透析器的凝血。主要发现及其重要性是什么?当向模型中添加清除率降低时,24 个模型模拟中有 17 个得到了改善。因此,该动力学模型似乎很有前途,可以成为血液透析患者凝血问题定量检测的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/617a7aa7637d/EPH-108-1325-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/78c8314cfe8b/EPH-108-1325-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/58d3dccc23a5/EPH-108-1325-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/825c500db1dd/EPH-108-1325-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/617a7aa7637d/EPH-108-1325-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/78c8314cfe8b/EPH-108-1325-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/58d3dccc23a5/EPH-108-1325-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/825c500db1dd/EPH-108-1325-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a926/10996865/617a7aa7637d/EPH-108-1325-g002.jpg

相似文献

1
Implementation of a coagulation component into a phosphate kinetics model in haemodialysis therapy: A tool for detection of clotting problems?在血液透析治疗中实现凝血成分到磷酸盐动力学模型中:一种检测凝血问题的工具?
Exp Physiol. 2023 Oct;108(10):1325-1336. doi: 10.1113/EP091201. Epub 2023 Aug 11.
2
Evaluation of a phosphate kinetics model in hemodialysis therapy-Assessment of the temporal robustness of model predictions.评估血液透析治疗中的磷酸盐动力学模型 - 评估模型预测的时间鲁棒性。
Physiol Rep. 2023 Dec;11(24):e15899. doi: 10.14814/phy2.15899.
3
Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.使用肝素化聚丙烯腈膜和富含柠檬酸盐的透析液进行间歇性血液透析时避免全身抗凝:一项回顾性队列研究。
BMC Nephrol. 2014 Jul 3;15:104. doi: 10.1186/1471-2369-15-104.
4
A single dose of dalteparin effectively prevents clotting during haemodialysis.单次剂量的达肝素可有效预防血液透析期间的凝血。
Nephrol Dial Transplant. 1999 Aug;14(8):1943-7. doi: 10.1093/ndt/14.8.1943.
5
Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.使用肝素涂层聚丙烯腈膜进行血液透析时的最佳抗凝策略。
Nephrol Dial Transplant. 2003 Oct;18(10):2097-104. doi: 10.1093/ndt/gfg272.
6
The impact of intradialytic cycling on the removal of protein-bound uraemic toxins: A randomised cross-over study.透析中循环对蛋白结合尿毒症毒素清除的影响:一项随机交叉研究。
Int J Artif Organs. 2021 Mar;44(3):156-164. doi: 10.1177/0391398820949880. Epub 2020 Aug 21.
7
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.间歇性血液透析期间四种低剂量抗凝模式的评估
Eur J Clin Pharmacol. 2018 Mar;74(3):267-274. doi: 10.1007/s00228-017-2389-x. Epub 2017 Dec 2.
8
Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.碳酸氢盐血液透析中柠檬酸盐与醋酸盐透析液的比较:对血流动力学、凝血、酸碱状态和电解质的影响
BMC Nephrol. 2009 Mar 5;10:7. doi: 10.1186/1471-2369-10-7.
9
Phosphate kinetics during different dialysis modalities.不同透析方式下的磷动力学
Blood Purif. 2005;23(1):83-90. doi: 10.1159/000082016.
10
Risk factors of system clotting in heparin-free haemodialysis.无肝素血液透析中系统凝血的危险因素。
Nephrol Dial Transplant. 1990;5(9):802-7. doi: 10.1093/ndt/5.9.802.

本文引用的文献

1
Risk factors for intracerebral hemorrhage in patients undergoing maintenance hemodialysis.维持性血液透析患者脑出血的危险因素。
Front Neurol. 2023 Mar 22;14:1111865. doi: 10.3389/fneur.2023.1111865. eCollection 2023.
2
Effect of dialyzer geometry on coagulation activation in the extracorporeal circuit in maintenance hemodialysis patients: Prospective randomized trial.维持性血液透析患者体外循环中透析器几何形状对凝血激活的影响:前瞻性随机试验。
Ther Apher Dial. 2023 Aug;27(4):629-635. doi: 10.1111/1744-9987.13975. Epub 2023 Feb 19.
3
A Role of Circuit Clotting and Strategies to Prevent It during Blood Purification Therapy with oXiris Membrane: An Observational Multicenter Study.
回路凝血的作用及使用oXiris膜进行血液净化治疗期间预防回路凝血的策略:一项多中心观察性研究。
Blood Purif. 2022 Apr 26:1-10. doi: 10.1159/000524230.
4
Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation.血液透析中的血型不相容性:减轻炎症及凝血作用
Clin Kidney J. 2021 Dec 27;14(Suppl 4):i59-i71. doi: 10.1093/ckj/sfab185. eCollection 2021 Dec.
5
Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.急性肾损伤行肾脏替代治疗患者的抗凝治疗。
Pediatr Nephrol. 2022 Oct;37(10):2303-2330. doi: 10.1007/s00467-021-05020-z. Epub 2021 Oct 19.
6
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.非药物干预措施预防连续性肾脏替代治疗中体外循环凝血。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
7
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial.无肝素血液透析中接触激活抑制剂 AB023:一项随机 2 期临床试验结果。
Blood. 2021 Dec 2;138(22):2173-2184. doi: 10.1182/blood.2021011725.
8
Renal Association Clinical Practice Guideline on Haemodialysis.英国肾脏病学会血液透析临床实践指南
BMC Nephrol. 2019 Oct 17;20(1):379. doi: 10.1186/s12882-019-1527-3.
9
Strategies for Phosphate Control in Patients With CKD.慢性肾脏病患者磷酸盐控制策略
Kidney Int Rep. 2019 Jun 20;4(8):1043-1056. doi: 10.1016/j.ekir.2019.06.002. eCollection 2019 Aug.
10
Hemodialysis-induced changes in hematocrit, hemoglobin and total protein: Implications for relative blood volume monitoring.血液透析引起的血细胞比容、血红蛋白和总蛋白的变化:对相对血容量监测的影响。
PLoS One. 2019 Aug 12;14(8):e0220764. doi: 10.1371/journal.pone.0220764. eCollection 2019.